[Brief] TrumpRx Platform Adds Hundreds of Generic Drugs Trump’s TrumpRx prescription drug platform has announced the addition of hundreds of generic medications, aiming to lower drug prices in the US. The expansion is part of the administration’s effort to reduce healthcare costs.
The FDA commissioner publicly defended the agency’s drug approval decisions, responding to criticism from pharmaceutical companies and some lawmakers, emphasizing that approval standards will not be lowered under political pressure.
The FDA has granted expanded access to Revolution Medicines’ targeted pancreatic cancer drug daraxonrasib, opening a pathway for more patients to receive a therapy that has shown promising results in clinical trials.
A US federal appeals court issued a temporary order blocking the FDA’s rule allowing women to obtain the abortion drug mifepristone by mail, a ruling that will impact drug accessibility nationwide.
BBC reports that AI technology is helping doctors detect previously missed sperm in semen samples from men diagnosed with azoospermia, bringing new hope to millions of infertile men worldwide.